Skip to content

A prospective, multi-centre randomised comparative study of implant fit, clinical outcomes and satisfaction with the Stryker Accolade II Hip Stem compared to the Corail Hip Stem

A prospective, multi-centre randomised comparative study of implant fit, clinical outcomes and satisfaction with the Stryker Accolade II Hip Stem compared to the Corail Hip Stem

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12613000629730
Acronym
Accolade II-12
Enrollment
304
Registered
2013-06-03
Start date
2013-08-13
Completion date
2018-12-07
Last updated
2022-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This study is a prospective, multi-centre, randomised clinical study comparing the preoperative radiographic plan to the intra-operative femoral stem sizing, and assessing post-operative fit, clinical and satisfaction outcomes. The study will be conducted in patients with Non-inflammatory Degenerative Joint Disease. In addition, a substudy is running in NZ to evaluate the differences in peri-prosthetic bone remodelling post hip replacement in 3 different femoral component implants. The Lunar iDXA (GE Healthcare, Madison, WI) densitometer is a Food and Drug Administration (FDA) - approved device for measuring BMD and body composition. The relationship between bone loss, patient functional outcome and implant survival across the 3 femoral stems will also be investigated.

Interventions

Patients randomised to this group will recieve an Accolade II Hip Stem. Duration of surgery is approximately 1.5hours.

Sponsors

Stryker Australia Pty Ltd
Lead SponsorCommercial sector/Industry

Study design

Allocation
Randomised controlled trial
Primary purpose
Treatment
Masking
Blinded (masking used) (Subject)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1.Patient are male or non-pregnant females requiring a cementless THR for non-inflammatory degenerative joint disease of the hip. 2.Must be older than 18 years

Exclusion criteria

1. Patient has a cognitive impairment, an intellectual disability or a mental illness 2. People whose primary language is other than English 3. Pregnant Women 4. Children and or/young people (ie. <18 years)

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026